Latest Reports 
Results,Reports And Presentations +6% Revenue growth at constant (and 8% in actual terms)
19% Increase in pre-R&D operating profit to £16.9m (2020: £14.2m)
£40.3m Strong cash balance at 30 June 2021 (2020: £37.0m)
£2.9m Net profit for the year (2020: Net profit of £7.1m including cash settlement of £3.2m)
Our year in numbers
2021 was another record level of pre-R&D operating profit ahead of market expectations reflecting continued sales growth.
Annual Report 2021
Allergies reduce quality of life by preventing individuals and their loved ones from enjoying the everyday activities most take for granted. At their most severe, they can be fatal.
Transforming lives
Specialist expertise drives and inspires us to discover more, helping us to improve patients' lives.
Specialist expertise
To achieve our vision and fulfil our mission, we develop treatments that are as convenient as they are effective.
Delivering convenience
Take your career to new heights
Our culture and values